carubicin

This page covers all carubicin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting DNA topoisomerase 2-alpha.

Targets

DNA topoisomerase 2-alpha

Phase 2 pipeline (1)

• Carminomicin I · Other
  CARUBICIN works by binding to DNA topoisomerase 2-alpha, preventing the enzyme from unwinding DNA and leading to cell death.

Patent intelligence

• carubicin patent landscape — aggregated cliff calendar, attackable patents, originator estates